Value of hypersensitive C-reactive protein for predicting the prognosis of patients after emergent percutaneous coronary intervention

Li Lei,Guo Yanhong,Wang Guisong

DOI: https://doi.org/10.3969/j.issn.1009-6604.2006.07.002

2006-01-01

Abstract:Objective To evaluate the value of hypersensitive C-reactive protein(hs-CRP) for predicting the incidence of major adverse cardiac events(MACE) in patients with acute myocardial infarction(AMI) within 180 days after percutaneous coronary intervention(PCI). Methods The study comprised 216 consecutive patients with first attack of ST-elevation myocardial infarction(STEMI).They underwent primary PCI within 12 hours after the onset of chest pain.According to their serum levels of hs-CRP,these patients were divided into two groups: the High hs-CRP Group(>3 mg/L,n=52) and the Normal hs-CRP Group(≤ 3 mg/L,n=164).The incidence of MACE within 180 postoperative days was followed.Results There were no significant differences in age,hypertension,hyperlipidemia,left ventricle ejection fraction(LVEF),creatine kinase isoenzyme MB(CK-MB),and immediate success rate of PCI between the two groups(P<0.05).The WBC count was higher in the High hs-CRP Group than in the Normal hs-CRP Group(P<0.05).Follow-up for 180 days showed the High hs-CRP Group had significantly higher incidence of MACE than the Normal hs-CRP Group(22.0% vs 9.6%,P=0.048).Binary logistic regression analysis indicated that high concentration of hs-CRP remained an independent predicator of MACE within 180 postoperative days(OR=2.82,95% CI=1.28~5.83,P=0.021). Conclusions High concentration of hs-CRP when admission is a useful predictor for the incidence of MACE in patients with STEMI within 180 days after primary PCI.